Clinical trials
Placebo - Control clinical trials
Below are recruiting placebo - control clinical trials, each written for real people, not researchers. We’re tracking 3,904 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07085507RecruitingPhase 1/Phase 2
Testing a new drug for multiple sclerosis in healthy people and MS patients
This trial tests an experimental oral drug called VT7208 in both healthy volunteers and people with multiple sclerosis (MS). The goal is to see if it is safe and how the body processes it, which could lead to a new treatment option for MS.
Adelaide, South AustraliaAges 18–65 - NCT07082842RecruitingPhase 3
Testing HEC585 tablets for idiopathic pulmonary fibrosis
This trial tests a new tablet, HEC585, for people with idiopathic pulmonary fibrosis (IPF). It aims to see if the drug can help improve lung function and slow the disease. Participants must have a confirmed IPF diagnosis and meet specific breathing test results.
Beijing, Beijing MunicipalityAges 40–80 - NCT07083882RecruitingPhase 2
Capsule transplant for newly diagnosed type 1 diabetes
This study tests if taking capsules with processed donor stool can help preserve insulin-making cells in people recently diagnosed with type 1 diabetes. The treatment aims to slow the loss of insulin production.
AmsterdamAges 18–45 - NCT07077395RecruitingPhase 2
Hot flash study to check heart health links
This study looks at how hot flashes in midlife women might be connected to heart disease risk. Researchers want to see if managing hot flashes can improve heart health.
Boston, MassachusettsAges 40–65 - NCT07078344RecruitingPhase 2
Omega-3 study for healthy African American and European American adults
This study tests whether taking omega-3 supplements can improve health and reduce diet-related differences between African American and European American adults. You would take daily capsules and visit the clinic regularly for about 6 months.
Tucson, ArizonaAges 18–64 - NCT07083635RecruitingPhase 2
Hormonal patch for irregular bleeding with contraceptive implant
This trial tests a skin patch containing two hormones (estrogen and progestin) to see if it can stop irregular bleeding in women who have a contraceptive implant. If you're having unpredictable or prolonged bleeding with your implant, this treatment may help regulate your periods.
Pathum Wan, BangkokAges 18 years+ - NCT07076849RecruitingPhase 2
Probiotics for Iron in Pregnancy
This trial tests if taking a probiotic can help improve iron levels and overall blood health in pregnant women who are at risk for iron deficiency. If you are between 10 and 16 weeks pregnant with a single baby and have slightly low iron, this study may help you.
Chicago, IllinoisAges 18–45 - NCT06974994Recruiting
Antibiotic Use in Newborns and Gut Bacteria Health Study
This study explores how antibiotics given during delivery affect a baby's gut bacteria and long-term health. If you are pregnant or just gave birth and received antibiotics during labor, you and your newborn may be able to join.
Turku, Valitse Maakunta.Ages 2 hours+ - NCT04818203RecruitingPhase 1/Phase 2
Autologous fibroblast injections for crow’s feet wrinkles
This study tests a safety and effectiveness approach for reducing crow’s feet (wrinkles at the outer corners of the eyes) using cells made from your own skin. You may be asked to stop other wrinkle treatments and have blood tests and injections at a specific skin area.
SeoulAges 19 years+ - NCT06959043Recruiting
Diet and exercise for type 2 diabetes
This study tests if a plant-based diet and exercise program can improve blood sugar control in people with type 2 diabetes. Participants will live in a hospital for 4 weeks to follow the program closely.
São Paulo, São PauloAges 45–70 - NCT06900920RecruitingPhase 3
Study of TQB3473 tablets for adults with chronic immune thrombocytopenia
This trial tests an investigational tablet called TQB3473 against placebo for adults with primary immune thrombocytopenia (ITP) that has lasted at least a year and hasn't responded well to standard treatments. The goal is to see if the drug can safely increase platelet counts and reduce bleeding risk.
Hefei, AnhuiAges 18–75 - NCT06980675Recruiting
Ozonized olive oil for gum disease treatment
This trial tests if a special ozonized olive oil gel can help treat deep gum pockets caused by periodontitis (advanced gum disease). If you have gum pockets that are 4 mm or deeper, this could be an option to reduce infection and improve healing.
Bari, BAAges 18 years+ - NCT06488001RecruitingPhase 2
Preventing nausea after gynecologic surgery with pantoprazole
This trial tests if giving pantoprazole before surgery can reduce nausea and vomiting after gynecologic procedures. It may help patients who are having gynecologic surgery under general anesthesia.
Portsmouth, VirginiaAges 18–79 - NCT06937294RecruitingPhase 4
Metformin for diabetes from chronic pancreatitis
This trial tests if metformin is safe and effective for people who developed diabetes after being diagnosed with chronic pancreatitis. You must not have taken any diabetes medication before.
Shanghai, Shanghai MunicipalityAges 18–65 - NCT07069426Recruiting
Protein and muscle loss during leg immobilization
This study tests how different amounts of dietary protein affect your muscles when your leg is temporarily immobilized in a brace. If you are a healthy, active adult, you might help researchers learn how to prevent muscle loss during periods of reduced activity.
Natick, MassachusettsAges 17–39 - NCT07072624RecruitingPhase 4
Preventing seizures after severe head injury
This trial tests whether giving medication right after a serious head injury can prevent early seizures. It may help people with certain types of brain injuries seen on CT scans.
Chandigarh, PunjabAges 18–70 - NCT07073846RecruitingPhase 4
Lidocaine and dexmedetomidine for pain after weight-loss surgery
This study tests whether adding two medicines (lidocaine and dexmedetomidine) to your anesthesia during weight-loss surgery can reduce pain, swelling, and stress on the body. It might help you have a smoother recovery.
Mexico City, Mexico CityAges 18–60 - NCT07072468RecruitingPhase 2
Test of a gel for nerve pain after chemotherapy
This study tests a new gel (VMD-3866) applied to the skin to treat moderate nerve pain, numbness, or tingling caused by previous chemotherapy. It aims to see if the gel can safely reduce pain for people whose symptoms have been stable for at least 8 weeks.
London, UKAges 18–80 - NCT07065240RecruitingPhase 2
Study of SPT-300 for major depression with or without anxiety
This trial tests an experimental oral medication, SPT-300, for people with major depressive disorder, even if they also have mild anxiety. The goal is to see if it helps improve mood safely.
Chino, CaliforniaAges 18–65 - NCT07071623RecruitingPhase 3
A study of an experimental drug to prevent HIV
This trial tests a new medication called MK-8527 to see if it can prevent HIV-1 infection in women who are at risk. If you are a cisgender woman, HIV-negative, and sexually active, this study could be an option for you.
Homabay County, Homa Bay CountyAges 16–30 - NCT07072195RecruitingPhase 2
A study of AMC6156 for people with muscle loss
This trial tests an investigational drug called AMC6156 to see if it can help improve muscle mass and strength in older adults with sarcopenia (age-related muscle loss). Participants will also follow exercise and nutrition guidance.
Seongnam-si, Gyeonggi-doAges 65 years+ - NCT07066098RecruitingPhase 3
New drug IBI343 for advanced pancreatic cancer with CLDN18.2 protein
This study tests a new drug called IBI343 compared to a placebo (inactive substance) for people with advanced pancreatic cancer that has a specific protein (CLDN18.2) and has not responded to earlier treatments. The goal is to see if IBI343 can help slow the cancer's growth.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07067463RecruitingPhase 3
Testing orelabrutinib for primary progressive MS
This trial tests a daily pill called orelabrutinib to see if it can slow disability progression in people with primary progressive multiple sclerosis (PPMS). It may be an option for patients whose symptoms have been getting worse over the past two years.
Pheonix, ArizonaAges 18–60 - NCT07073677RecruitingPhase 2
Testing a new eczema ointment for mild to moderate cases
This study tests a new ointment called IN-115314 for adults with mild to moderate eczema. Researchers want to see if it helps control symptoms like itching and redness better than a placebo, and check that it's safe to use.
Ansan, ALLAges 19 years+
Hear when a new Placebo - Control trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo - control?
- Yes. Clin2 currently lists 3,904 recruiting placebo - control studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo - control trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo - control trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.